We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.62B
AUM Growth
+$99.5M
Cap. Flow
-$24.9M
Cap. Flow %
-1.54%
Top 10 Hldgs %
17.08%
Holding
826
New
61
Increased
333
Reduced
360
Closed
60
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
451
HCA Healthcare
HCA
$89.1B
$626K 0.04%
+2,607
New +$584K
TT icon
452
Trane Technologies
TT
$106B
$615K 0.04%
+3,659
New +$604K
INO icon
453
Inovio Pharmaceuticals
INO
$79.1M
$613K 0.04%
32,764
+3,371
+11% +$76.4K
ICFI icon
454
ICF International
ICFI
$1.62B
$610K 0.04%
6,157
-198
-3% -$21.6K
VIAV icon
455
Viavi Solutions
VIAV
$9.47B
$610K 0.04%
58,013
-27,489
-32% -$331K
FT
456
Franklin Universal Trust
FT
$198M
$607K 0.04%
90,194
-11,721
-12% -$78.2K
JJSF icon
457
J&J Snack Foods
JJSF
$1.68B
$605K 0.04%
4,041
-205
-5% -$30.4K
AROC icon
458
Archrock
AROC
$5.78B
$601K 0.04%
66,933
-2,846
-4% -$22.8K
META icon
459
Meta Platforms (Facebook)
META
$1.53T
$600K 0.04%
4,990
-4,252
-46% -$499K
BNS icon
460
Scotiabank
BNS
$108B
$599K 0.04%
12,235
-468
-4% -$23.1K
VTWO icon
461
Vanguard Russell 2000 ETF
VTWO
$17.3B
$595K 0.04%
8,459
-502
-6% -$36.1K
ALSN icon
462
Allison Transmission
ALSN
$10.3B
$592K 0.04%
14,236
+1,977
+16% +$81.2K
ITCI
463
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$590K 0.04%
+11,148
New +$559K
BDX icon
464
Becton Dickinson
BDX
$49.4B
$587K 0.04%
2,307
-76
-3% -$17.9K
CTBI icon
465
Community Trust Bancorp
CTBI
$1.42B
$587K 0.04%
12,783
+924
+8% +$42.1K
DT icon
466
Dynatrace
DT
$14.4B
$586K 0.04%
15,311
+3,274
+27% +$119K
BIIB icon
467
Biogen
BIIB
$30.1B
$579K 0.04%
+2,090
New +$590K
GGG icon
468
Graco
GGG
$13.5B
$577K 0.04%
8,586
+1,255
+17% +$83.7K
ASND icon
469
Ascendis Pharma A/S
ASND
$16.7B
$575K 0.04%
+4,710
New +$547K
CTVA icon
470
Corteva
CTVA
$50.9B
$573K 0.04%
+9,756
New +$617K
DHI icon
471
D.R. Horton
DHI
$42.2B
$572K 0.04%
6,414
-206
-3% -$16.5K
APTV icon
472
Aptiv
APTV
$10.3B
$568K 0.04%
+6,097
New +$580K
CAG icon
473
Conagra Brands
CAG
$7.14B
$568K 0.04%
+14,666
New +$532K
IIIN icon
474
Insteel Industries
IIIN
$633M
$568K 0.04%
20,623
-1,694
-8% -$46.4K
KOF icon
475
Coca-Cola Femsa
KOF
$23B
$565K 0.03%
8,318
+1,257
+18% +$81.8K

Similar funds

Hennion & Walsh Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Hennion & Walsh Asset Management held 826 positions worth $1.62B, up 6.5% from $1.52B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hennion & Walsh Asset Management's Q4 2022 filing shows 61 new, 333 increased, 360 reduced and 60 closed positions. Its largest new stake was ConocoPhillips: 5,945 shares worth $702K. The largest sale was Global Blood Therapeutics, Inc., an estimated $8.48M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q4 2022 buy was ConocoPhillips: 5,945 shares worth $702K.
  • Hennion & Walsh Asset Management added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $7.48M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2022 reduction was Nuveen Municipal Credit Income Fund, cutting an estimated $7.27M.
  • Hennion & Walsh Asset Management fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $8.48M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $1.62B portfolio in Q4 2022.
  • Hennion & Walsh Asset Management opened 61 new positions and closed 60 in Q4 2022.
  • Hennion & Walsh Asset Management's portfolio value rose 6.5% quarter-over-quarter to $1.62B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.